Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -155,127 | -97,773 | -116,426 | -104,793 | -30,692 |
| Depreciation Amortization | -575 | 644 | 741 | 852 | 323 |
| Income taxes - deferred | 529 | -1,058 | N/A | N/A | N/A |
| Accounts receivable | N/A | 94 | -64 | 21 | 285 |
| Accounts payable and accrued liabilities | 7,788 | 2,419 | 2,122 | -420 | -1,342 |
| Other Working Capital | 19,415 | 2,864 | 9,493 | -9,413 | 3,542 |
| Other Operating Activity | 9,801 | 12,319 | 12,877 | 11,472 | 5,078 |
| Operating Cash Flow | $-118,169 | $-80,492 | $-91,257 | $-102,280 | $-22,807 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -391 | -723 | -49 | -861 | -12 |
| Purchase Of Investment | -271,157 | -520,927 | -395,757 | -514,308 | -103,602 |
| Sale Of Investment | 406,189 | 428,933 | 488,069 | 153,390 | 36,879 |
| Investing Cash Flow | $134,641 | $-92,718 | $92,262 | $-361,779 | $-66,734 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 125,000 | N/A | N/A |
| Common Stock Issued | 685 | 162,357 | 478 | 450,650 | 116,464 |
| Other Financing Activity | 0 | 0 | -125,000 | -756 | -749 |
| Financing Cash Flow | $685 | $162,357 | $478 | $449,894 | $115,716 |
| Beginning Cash Position | 37,790 | 48,642 | 47,159 | 61,325 | 35,151 |
| End Cash Position | 54,948 | 37,790 | 48,642 | 47,159 | 61,325 |
| Net Cash Flow | $17,157 | $-10,852 | $1,483 | $-14,166 | $26,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | -118,169 | -80,492 | -91,257 | -102,280 | -22,807 |
| Capital Expenditure | -391 | -723 | -49 | -861 | -12 |
| Free Cash Flow | -118,560 | -81,215 | -91,306 | -103,141 | -22,819 |